Timothy L McMurry1, George J Stukenborg1, Larry G Kessler2, Graham A Colditz3, Melisa L Wong4, Amanda B Francescatti5, David R Jones6, Jessica R Schumacher7, Caprice C Greenberg7, George J Chang8, David P Winchester5, Daniel P McKellar5, Benjamin D Kozower3. 1. Department of Public Health Sciences, University of Virginia Health System, Charlottesville, VA. 2. Department of Health Services, School of Public Health, University of Washington, Seattle, WA. 3. Divisions of Cardiothoracic Surgery and Public Health Sciences, Washington University School of Medicine, St. Louis, MO. 4. Divisions of Hematology/Oncology, University of California San Francisco, San Francisco, CA. 5. Commission on Cancer and Cancer Programs, American College of Surgeons, Chicago, IL. 6. Thoracic Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. 7. Department of Surgery, University of Wisconsin, Madison, WI. 8. Department of Surgical Oncology and Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
Abstract
OBJECTIVE: To evaluate whether an association exists between the intensity of surveillance following surgical resection for non-small cell lung cancer (NSCLC) and survival. BACKGROUND: Surveillance guidelines following surgical resection of NSCLC vary widely and are based on expert opinion and limited evidence. METHODS: A Special Study of the National Cancer Database randomly selected stage I to III NSCLC patients for data reabstraction. For patients diagnosed between 2006 and 2007 and followed for 5 years through 2012, registrars documented all postsurgical imaging with indication (routine surveillance, new symptoms), recurrence, new primary cancers, and survival, with 5-year follow-up. Patients were placed into surveillance groups according to existing guidelines (3-month, 6-month, annual). Overall survival and survival after recurrence were analyzed using Cox Proportional Hazards Models. RESULTS: A total of 4463 patients were surveilled with computed tomography scans; these patients were grouped based on time from surgery to first surveillance. Groups were similar with respect to age, sex, comorbidities, surgical procedure, and histology. Higher-stage patients received more surveillance. More frequent surveillance was not associated with longer risk-adjusted overall survival [hazard ratio for 6-month: 1.16 (0.99, 1.36) and annual: 1.06 (0.86-1.31) vs 3-month; P value 0.14]. More frequent imaging was also not associated with postrecurrence survival [hazard ratio: 1.02/month since imaging (0.99-1.04); P value 0.43]. CONCLUSIONS: These nationally representative data provide evidence that more frequent postsurgical surveillance is not associated with improved survival. As the number of lung cancer survivors increases over the next decade, surveillance is an increasingly important major health care concern and expenditure.
OBJECTIVE: To evaluate whether an association exists between the intensity of surveillance following surgical resection for non-small cell lung cancer (NSCLC) and survival. BACKGROUND: Surveillance guidelines following surgical resection of NSCLC vary widely and are based on expert opinion and limited evidence. METHODS: A Special Study of the National Cancer Database randomly selected stage I to III NSCLC patients for data reabstraction. For patients diagnosed between 2006 and 2007 and followed for 5 years through 2012, registrars documented all postsurgical imaging with indication (routine surveillance, new symptoms), recurrence, new primary cancers, and survival, with 5-year follow-up. Patients were placed into surveillance groups according to existing guidelines (3-month, 6-month, annual). Overall survival and survival after recurrence were analyzed using Cox Proportional Hazards Models. RESULTS: A total of 4463 patients were surveilled with computed tomography scans; these patients were grouped based on time from surgery to first surveillance. Groups were similar with respect to age, sex, comorbidities, surgical procedure, and histology. Higher-stage patients received more surveillance. More frequent surveillance was not associated with longer risk-adjusted overall survival [hazard ratio for 6-month: 1.16 (0.99, 1.36) and annual: 1.06 (0.86-1.31) vs 3-month; P value 0.14]. More frequent imaging was also not associated with postrecurrence survival [hazard ratio: 1.02/month since imaging (0.99-1.04); P value 0.43]. CONCLUSIONS: These nationally representative data provide evidence that more frequent postsurgical surveillance is not associated with improved survival. As the number of lung cancer survivors increases over the next decade, surveillance is an increasingly important major health care concern and expenditure.
Authors: Michael T Jaklitsch; Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; Scott J Swanson; William D Travis; David J Sugarbaker Journal: J Thorac Cardiovasc Surg Date: 2012-07 Impact factor: 5.209
Authors: Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen Journal: Radiology Date: 2005-11 Impact factor: 11.105
Authors: V Westeel; M P Lebitasy; M Mercier; P Girard; F Barlesi; F Blanchon; J Tredaniel; P Bonnette; M C Woronoff-Lemsi; J L Breton; R Azarian; P E Falcoz; S Friard; L Geriniere; S Laporte; E Lemarie; E Quoix; G Zalcman; J Guigay; F Morin; B Milleron; A Depierre Journal: Rev Mal Respir Date: 2007-05 Impact factor: 0.622
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer Journal: N Engl J Med Date: 2016-10-08 Impact factor: 91.245
Authors: Corey J Langer; Coleman Obasaju; Paul Bunn; Philip Bonomi; David Gandara; Fred R Hirsch; Edward S Kim; Ronald B Natale; Silvia Novello; Luis Paz-Ares; Maurice Pérol; Martin Reck; Suresh S Ramalingam; Craig H Reynolds; Mark A Socinski; David R Spigel; Heather Wakelee; Carlos Mayo; Nick Thatcher Journal: J Thorac Oncol Date: 2016-08-26 Impact factor: 15.609
Authors: Juliana B F Morellato; Marcos D Guimarães; Maria L L Medeiros; Hélio A Carneiro; Alex D Oliveira; João P O Medici; Marcus V B Baranauskas; Jefferson L Gross Journal: J Bras Pneumol Date: 2021-08-11 Impact factor: 2.624